相关实验视频

Updated: Jul 27, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

[结直肠癌的分子病理学]

Christine Woischke¹, Marlies Michl^2,3, Jens Neumann⁴

¹Pathologisches Institut, Medizinische Fakultät, Ludwig-Maximilians-Universität München, Thalkirchner Str. 36, 80337, München, Deutschland.

Pathologie (Heidelberg, Germany)

|June 5, 2023

概括

个性化结直肠癌治疗现在包括MSI,HER2状态和瘤位置. 分子诊断对于指导最佳的,基于证据的治疗和为新的向治疗做准备至关重要.

科学领域:

在瘤学瘤学.
分子病理学分子病理学
癌症的诊断癌症的诊断

关键词:

生物标志物生物标志物液体活检液体活检微卫星的不稳定性是微观的精准医学是一门精准的医学.原始原蛋白蛋白质B-raf 的存在.

更多相关视频

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...